Quarterly Result12 May 2026, 02:23 pm
Emmessar Biotech Approves Audited FY26 Financial Results
AI Summary
Emmessar Biotech & Nutrition Ltd's Board of Directors approved the audited standalone financial results for the year ended March 31, 2026, following a review by the Audit Committee. The board meeting, held on May 12, 2026, also included a declaration on the audit report with an unmodified opinion from V. Nagarajan & Co., Chartered Accountants.
Key Highlights
- Board approved audited standalone financial results for FY26.
- Audit Committee reviewed the financial results.
- Auditors issued an unmodified opinion on the financial results.
- Meeting commenced at 12:20 noon and concluded at U · 0 p . m .
Price Impact
More from EMMESSA